Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Raghu Prasad, Mailavaram"'
Autor:
Katharigatta N. Venugopala, Sandeep Chandrashekharappa, Christophe Tratrat, Pran Kishore Deb, Rahul D. Nagdeve, Susanta K. Nayak, Mohamed A. Morsy, Pobitra Borah, Fawzi M. Mahomoodally, Raghu Prasad Mailavaram, Mahesh Attimarad, Bandar E. Aldhubiab, Nagaraja Sreeharsha, Anroop B. Nair, Osama I. Alwassil, Michelyne Haroun, Viresh Mohanlall, Pottathil Shinu, Rashmi Venugopala, Mahmoud Kandeel, Belakatte P. Nandeshwarappa, Yasmine F. Ibrahim
Publikováno v:
Molecules, Vol 26, Iss 12, p 3550 (2021)
The cyclooxygenase-2 (COX-2) enzyme is an important target for drug discovery and development of novel anti-inflammatory agents. Selective COX-2 inhibitors have the advantage of reduced side-effects, which result from COX-1 inhibition that is usually
Externí odkaz:
https://doaj.org/article/a93033df97874456b6deecfd06366840
Autor:
Pobitra Borah, Sangeeta Hazarika, Mohamed A. Morsy, Manoj Goyal, Ashna Chettri, Katharigatta N. Venugopala, Viresh Mohanlall, Pratap Chandra Acharya, Pran Kishore Deb, Raghu Prasad Mailavaram
Publikováno v:
Medicinal Chemistry of Chemotherapeutic Agents ISBN: 9780323905756
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b66f76db5526104125c7d1eb1aff1453
https://doi.org/10.1016/b978-0-323-90575-6.00001-6
https://doi.org/10.1016/b978-0-323-90575-6.00001-6
Autor:
Naveen Kumar Reddy Chinnappanna, Gopi Yennam, Chaitanya Budagam Haima Naga Venkata Chaitanya, Shinu Pottathil, Pobitra Borah, Katharigatta N. Venugopala, Pran Kishore Deb, Raghu Prasad Mailavaram
Publikováno v:
Acta Pharmaceutica
Volume 73
Issue 1
Volume 73
Issue 1
Malaria is a serious worldwide medical issue that results in substantial annual death and morbidity. The availability of treatment alternatives is limited, and the rise of resistant parasite types has posed a significant challenge to malaria treatmen
Autor:
Katharigatta N. Venugopala, Vijayakumar Uppar, Sandeep Chandrashekharappa, Hassan H. Abdallah, Melendhran Pillay, Pran Kishore Deb, Mohamed A. Morsy, Bandar E. Aldhubiab, Mahesh Attimarad, Anroop B. Nair, Nagaraja Sreeharsha, Christophe Tratrat, Abdulmuttaleb Yousef Jaber, Rashmi Venugopala, Raghu Prasad Mailavaram, Bilal A. Al-Jaidi, Mahmoud Kandeel, Michelyne Haroun, Basavaraj Padmashali
Publikováno v:
Antibiotics, Vol 9, Iss 5, p 233 (2020)
A series of ethyl 1-(substituted benzoyl)-5-methylpyrrolo[1,2-a]quinoline-3-carboxylates 4a–f and dimethyl 1-(substituted benzoyl)-5-methylpyrrolo[1,2-a]quinoline-2,3-dicarboxylates 4g–k have been synthesized and evaluated for their anti-tubercul
Externí odkaz:
https://doaj.org/article/f25c1a746c5a4cdb8c1931de74c7a524
Autor:
Amavya Srivastava, Nizar A. Al-Shar’i, Raghu Prasad Mailavaram, Pobitra Borah, Vinayak Singh, Pran Kishore Deb, Satyendra Deka, Vinod Tiwari, Katharigatta N. Venugopala
Publikováno v:
Current Topics in Medicinal Chemistry. 21:547-570
Human tuberculosis (TB) is primarily caused by Mycobacterium tuberculosis (Mtb) that inhabits inside and amidst immune cells of the host with adapted physiology to regulate interdependent cellular functions with intact pathogenic potential. The compl
Autor:
Raghu Prasad Mailavaram, Anroop B. Nair, Supratik Kar, Bilal A. Al-Jaidi, Satya Sri Chitikina, Praveen Buddiga, Pran Kishore Deb, Katharigatta N. Venugopala
Publikováno v:
Medicinal Chemistry Research. 29:1600-1610
A series of some novel (E)-2-methyl/propyl-4-[(2-(substitutedbenzylidene)hydrazinyl]-5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidines was synthesized and characterized by adopting an appropriate synthetic scheme. The effect of electron withdrawin
Autor:
Mahesh Attimarad, Nagaraja Sreeharsha, Mahmoud Kandeel, Pobitra Borah, Anroop B. Nair, Raghu Prasad Mailavaram, Bandar E. Al-Dhubiab, Michelyne Haroun, Rashmi Venugopala, Mohamed A. Morsy, B.P. Nandeshwarappa, Osama I. Alwassil, Yasmine F. Ibrahim, Fawzi M. Mahomoodally, Rahul D. Nagdeve, Pran Kishore Deb, Christophe Tratrat, Sandeep Chandrashekharappa, Pottathil Shinu, Susanta K. Nayak, Viresh Mohanlall, Katharigatta N. Venugopala
Publikováno v:
Molecules, Vol 26, Iss 3550, p 3550 (2021)
Molecules
Volume 26
Issue 12
Molecules
Volume 26
Issue 12
The cyclooxygenase-2 (COX-2) enzyme is an important target for drug discovery and development of novel anti-inflammatory agents. Selective COX-2 inhibitors have the advantage of reduced side-effects, which result from COX-1 inhibition that is usually
Autor:
Raghu Prasad, Mailavaram, Raghuram Rao, Akkinepally, Shanthan Rao, Pamulaparthy, Rajan, Kombu Subramanian, Meena, Shanmugam, Madhavi, Kuchana
Publikováno v:
In European Journal of Medicinal Chemistry 2008 43(3):614-620
Autor:
Vinayak Singh, Raghu Prasad Mailavaram, Rakesh K. Tekade, Pobitra Borah, Wafa Hourani, Samanvai Reddy Tetali, Pran Kishore Deb, Katharigatta N. Venugopala, Eswar Kunapaeddi
Publikováno v:
Tuberculosis (Edinburgh, Scotland). 125
Tuberculosis (TB) is a communicable airborne infectious disease caused by the Mycobacterium tuberculosis (MTB) that primarily affects the lungs, and can disseminate to other parts of the body. MTB is one of the most dangerous pathogens, killing about
Autor:
Kiran Kalia, Satyendra Deka, Pran Kishore Deb, Rakesh K. Tekade, Katharigatta N. Venugopala, Raghu Prasad Mailavaram, Pobitra Borah, Vinayak Singh
Publikováno v:
Current medicinal chemistry. 28(2)
The COVID-19 pandemic continues to wreak havoc worldwide due to the lack of risk assessment, rapid spreading ability, and propensity to precipitate severe disease in comorbid conditions. In an attempt to fulfill the demand for prophylactic and treatm